Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)
Status:
Not yet recruiting
Trial end date:
2027-08-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how safe and how well-tolerated the experimental
study drug, C134 is when re-administered into the brain where the tumor is located.